Description: SS‑31 (also known as elamipretide) is a mitochondria‑targeted tetrapeptide that selectively binds cardiolipin, stabilizes mitochondrial inner‑membrane structure, reduces reactive oxygen species, and can improve mitochondrial bioenergetics in preclinical and clinical research models. Used in studies of mitochondrial dysfunction, ischemia–reperfusion injury, neurodegeneration, cardiomyopathy, and related bioenergetic investigations.
Intended use: RESEARCH CHEMICAL — for in vitro testing and laboratory or regulated clinical research by qualified professionals only. Not for administration to humans or animals outside approved studies. Not a drug, food, or cosmetic; do not misbrand, misuse, or mislabel.